Biotech

All Articles

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapies' $ 5.8 billion purchase to Bristol Mye...

Asarina to close after initiatives to companion Tourette's medicine neglect

.After connecting to much more than 200 providers to companion a Tourette disorder treatment that pr...

Novartis markers $150M in advance bispecifics handle Dren Bio

.Novartis has possessed some rotten luck with bispecific antitoxins in the past, yet evaluating due ...

AstraZeneca plants an EGFR tree with Pinetree deal worth $45M

.Pinetree Therapies are going to assist AstraZeneca vegetation some plants in its own pipe along wit...

GRO gathers $60M set B to take gout arthritis therapy in to center

.GRO Biosciences has finished the week along with an added $60.3 million in the banking company, whi...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses chief executive officer

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...